Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 12, 2019

Primary Completion Date

April 1, 2023

Study Completion Date

May 15, 2023

Conditions

Endometrial Endometrioid Adenocarcinoma

Interventions

DRUG

Abemaciclib

Given PO

DRUG

Letrozole

Given PO

PROCEDURE

Therapeutic Conventional Surgery

Undergo standard of care hysterectomy

Trial Locations (2)

Northwestern University, Chicago

University of Chicago Comprehensive Cancer Center, Chicago

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT04049227 - Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer | Biotech Hunter | Biotech Hunter